ID   PIM2_HUMAN              Reviewed;         311 AA.
AC   Q9P1W9; Q99739;
DT   27-MAR-2002, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2000, sequence version 1.
DT   02-NOV-2010, entry version 87.
DE   RecName: Full=Serine/threonine-protein kinase pim-2;
DE            EC=2.7.11.1;
DE   AltName: Full=Pim-2h;
GN   Name=PIM2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Testis;
RX   MEDLINE=99023748; PubMed=9804974; DOI=10.1016/S0167-4781(98)00185-7;
RA   Baytel D., Shalom S., Madgar I., Weissenberg R., Don J.;
RT   "The human Pim-2 proto-oncogene and its testicular expression.";
RL   Biochim. Biophys. Acta 1442:274-285(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RA   Ishida N., Miura N., Yamauchi M., Kawakita M.;
RT   "Genomic organization of the human UDP-galactose transporter gene.";
RL   Submitted (MAY-2000) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   INDUCTION, AND MASS SPECTROMETRY.
RX   PubMed=16548883; DOI=10.1111/j.1462-5822.2005.00644.x;
RA   Leong W.F., Chow V.T.;
RT   "Transcriptomic and proteomic analyses of rhabdomyosarcoma cells
RT   reveal differential cellular gene expression in response to
RT   enterovirus 71 infection.";
RL   Cell. Microbiol. 8:565-580(2006).
RN   [5]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-195 AND SER-204, AND
RP   MASS SPECTROMETRY.
RC   TISSUE=Embryonic kidney;
RX   PubMed=17287340; DOI=10.1073/pnas.0611217104;
RA   Molina H., Horn D.M., Tang N., Mathivanan S., Pandey A.;
RT   "Global proteomic profiling of phosphopeptides using electron transfer
RT   dissociation tandem mass spectrometry.";
RL   Proc. Natl. Acad. Sci. U.S.A. 104:2199-2204(2007).
RN   [6]
RP   FUNCTION, AND TISSUE SPECIFICITY.
RX   PubMed=18675992; DOI=10.1016/j.jss.2008.03.033;
RA   Gong J., Wang J., Ren K., Liu C., Li B., Shi Y.;
RT   "Serine/threonine kinase Pim-2 promotes liver tumorigenesis induction
RT   through mediating survival and preventing apoptosis of liver cell.";
RL   J. Surg. Res. 153:17-22(2009).
RN   [7]
RP   VARIANTS [LARGE SCALE ANALYSIS] ASP-138 AND VAL-280.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Promotes cell survival in response to a variety of
CC       proliferative signals via positive regulation of the I-kappaB
CC       kinase/NF-kappaB cascade; this process requires phosphorylation of
CC       MAP3K8/COT. Prevents apoptosis induced by growth factor withdrawal
CC       via inhibition of caspase-3 activation, and via phosphorylation of
CC       pro-apoptotic proteins. Inhibits BAD-induced cell death via
CC       phosphorylation of BAD. PIM2-mediated cell survival is glucose-
CC       dependent but independent of several AKT regulators such as PI3K,
CC       HSP-90 and TOR, indicating that PIM2 and PI3K/AKT/TOR function via
CC       distinct pathways. Involved in the positive regulation of
CC       chondrocyte survival and autophagy in the epiphyseal growth plate
CC       (By similarity).
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- TISSUE SPECIFICITY: Highly expressed in hematopoietic tissues, in
CC       leukemic and lymphoma cell lines, testis, small intestine, colon
CC       and colorectal adenocarcinoma cells. Weakly expressed in normal
CC       liver, but highly expressed in hepatocellular carcinoma tissues.
CC   -!- INDUCTION: Down-regulated in response to enterovirus 71 (EV71)
CC       infection.
CC   -!- PTM: Autophosphorylated (By similarity).
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. CAMK
CC       Ser/Thr protein kinase family. PIM subfamily.
CC   -!- SIMILARITY: Contains 1 protein kinase domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U77735; AAC78506.1; -; mRNA.
DR   EMBL; AB042425; BAA95613.1; -; Genomic_DNA.
DR   EMBL; BC018111; AAH18111.1; -; mRNA.
DR   IPI; IPI00332692; -.
DR   RefSeq; NP_006866.2; -.
DR   UniGene; Hs.496096; -.
DR   PDB; 2IWI; X-ray; 2.80 A; A/B=1-311.
DR   PDBsum; 2IWI; -.
DR   ProteinModelPortal; Q9P1W9; -.
DR   IntAct; Q9P1W9; 6.
DR   MINT; MINT-1432143; -.
DR   STRING; Q9P1W9; -.
DR   PhosphoSite; Q9P1W9; -.
DR   PRIDE; Q9P1W9; -.
DR   Ensembl; ENST00000376509; ENSP00000365692; ENSG00000102096.
DR   GeneID; 11040; -.
DR   KEGG; hsa:11040; -.
DR   UCSC; uc004dls.1; human.
DR   CTD; 11040; -.
DR   GeneCards; GC0XM048770; -.
DR   H-InvDB; HIX0203302; -.
DR   HGNC; HGNC:8987; PIM2.
DR   HPA; HPA000285; -.
DR   MIM; 300295; gene.
DR   PharmGKB; PA33319; -.
DR   eggNOG; prNOG17556; -.
DR   HOGENOM; HBG755340; -.
DR   HOVERGEN; HBG106681; -.
DR   InParanoid; Q9P1W9; -.
DR   OMA; AAIQHCH; -.
DR   OrthoDB; EOG9NGK66; -.
DR   PhylomeDB; Q9P1W9; -.
DR   BRENDA; 2.7.11.1; 247.
DR   NextBio; 41955; -.
DR   ArrayExpress; Q9P1W9; -.
DR   Bgee; Q9P1W9; -.
DR   CleanEx; HS_PIM2; -.
DR   Genevestigator; Q9P1W9; -.
DR   GermOnline; ENSG00000102096; Homo sapiens.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB.
DR   GO; GO:0006916; P:anti-apoptosis; IDA:UniProtKB.
DR   GO; GO:0008283; P:cell proliferation; TAS:ProtInc.
DR   GO; GO:0007140; P:male meiosis; TAS:ProtInc.
DR   GO; GO:0010508; P:positive regulation of autophagy; ISS:UniProtKB.
DR   GO; GO:0043123; P:positive regulation of I-kappaB kinase/NF-k...; ISS:UniProtKB.
DR   GO; GO:0006468; P:protein amino acid phosphorylation; IDA:UniProtKB.
DR   GO; GO:0009615; P:response to virus; IEP:UniProtKB.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_cat_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR017442; Se/Thr_prot_kinase-like_dom.
DR   InterPro; IPR008271; Ser/Thr_prot_kinase_AS.
DR   InterPro; IPR002290; Ser/Thr_prot_kinase_dom.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; Kinase_like; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Apoptosis; ATP-binding; Complete proteome; Kinase;
KW   Nucleotide-binding; Phosphoprotein; Polymorphism;
KW   Serine/threonine-protein kinase; Transferase.
FT   CHAIN         1    311       Serine/threonine-protein kinase pim-2.
FT                                /FTId=PRO_0000086532.
FT   DOMAIN       32    286       Protein kinase.
FT   NP_BIND      38     46       ATP (By similarity).
FT   ACT_SITE    163    163       Proton acceptor (By similarity).
FT   BINDING      61     61       ATP (By similarity).
FT   MOD_RES     195    195       Phosphothreonine.
FT   MOD_RES     204    204       Phosphoserine.
FT   VARIANT     138    138       G -> D (in dbSNP:rs35044770).
FT                                /FTId=VAR_041008.
FT   VARIANT     280    280       I -> V (in dbSNP:rs35208542).
FT                                /FTId=VAR_041009.
FT   CONFLICT    294    311       PLNPSKGGPAPLAWSLLP -> TPQPLQRRPCPFGLVLATL
FT                                SLAWPGLAPNGQKSHPMAMSQG (in Ref. 1).
FT   HELIX        25     29
FT   STRAND       33     41
FT   STRAND       44     50
FT   TURN         52     54
FT   STRAND       57     62
FT   TURN         66     68
FT   HELIX        82     91
FT   STRAND       97     99
FT   STRAND      102    105
FT   STRAND      113    117
FT   STRAND      120    124
FT   HELIX       125    132
FT   HELIX       137    157
FT   HELIX       166    168
FT   STRAND      169    172
FT   TURN        173    176
FT   STRAND      177    180
FT   TURN        201    203
FT   HELIX       206    211
FT   HELIX       216    233
FT   HELIX       241    246
FT   HELIX       257    266
FT   TURN        271    273
FT   HELIX       277    282
FT   TURN        284    286
SQ   SEQUENCE   311 AA;  34190 MW;  160E56C368C67A69 CRC64;
     MLTKPLQGPP APPGTPTPPP GGKDREAFEA EYRLGPLLGK GGFGTVFAGH RLTDRLQVAI
     KVIPRNRVLG WSPLSDSVTC PLEVALLWKV GAGGGHPGVI RLLDWFETQE GFMLVLERPL
     PAQDLFDYIT EKGPLGEGPS RCFFGQVVAA IQHCHSRGVV HRDIKDENIL IDLRRGCAKL
     IDFGSGALLH DEPYTDFDGT RVYSPPEWIS RHQYHALPAT VWSLGILLYD MVCGDIPFER
     DQEILEAELH FPAHVSPDCC ALIRRCLAPK PSSRPSLEEI LLDPWMQTPA EDVPLNPSKG
     GPAPLAWSLL P
//
